One obvious answer is the drug companies won’t make $80billion profit a year from ivermectin because it’s an old, safe drug that’s off-patent. Costs a couple of bucks per treatment. That just won’t do for #Big Pharma. Are there other plausible reasons?
-
-
Show this threadThanks. Twitter will use this to make your timeline better. UndoUndo
-
-
-
you cant know everything all the time...or actually if you are amanda devine perhaps you can?
Thanks. Twitter will use this to make your timeline better. UndoUndo
-
-
-
Because the NIH are trialling far superior therapeutics.
-
It is a respiratory virus. Therefore, it makes sense to pursue therapeutics that can do good directly in the lung. For example: SNG001
End of conversation
New conversation -
Loading seems to be taking a while.
Twitter may be over capacity or experiencing a momentary hiccup. Try again or visit Twitter Status for more information.